Zobrazeno 1 - 10
of 42
pro vyhledávání: '"A U, Sabitov"'
Autor:
Alebai U. Sabitov, Dmitry A. Lioznov, Konstantin V. Zhdanov, Elena P. Tikhonova, Elena V. Esaulenko, Olga P. Kovtun, Pavel L. Kuznetsov, Pavel V. Sorokin
Publikováno v:
Терапевтический архив, Vol 96, Iss 5, Pp 517-522 (2024)
Aim. To evaluate the efficacy and safety of riamilovir in the treatment of COVID-19 in adults. Materials and methods. The study included 180 patients with a laboratory-confirmed diagnosis of COVID-19 which fully meet the criteria for inclusion, no
Externí odkaz:
https://doaj.org/article/f1ec0fff22f44911a4bc479467ff7248
Autor:
A. U. Sabitov, E. P. Tikhonova, E. V. Esaulenko, P. L. Kuznetsov, A. A. Sharova, T. A. Yelistratova, Yu. S. Kalinina, I. V. Andreeva, V. V. Basina, E. V. Oleinichenko, A. S. Edin
Publikováno v:
Антибиотики и Химиотерапия, Vol 69, Iss 1-2, Pp 37-43 (2024)
The aim of the study was to compare the clinical efficacy and safety of two antiviral therapy medications that suppress viral replication (viral RNA polymerase inhibitors) in the treatment of patients with COVID-19: favipiravir and riamilovir.Materia
Externí odkaz:
https://doaj.org/article/5a6f0e82d0dd43d08ef8e22848dedffa
Autor:
Alebai U. Sabitov, Dmitry A. Lioznov, Konstantin V. Zhdanov, Elena P. Tihonova, Elena V. Esaulenko, Pavel V. Sorokin
Publikováno v:
Терапевтический архив, Vol 96, Iss 3, Pp 280-285 (2024)
Aim. Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with COVID-19 patients as a result of living together. Materials and methods. The study i
Externí odkaz:
https://doaj.org/article/e8db1998a7524a51b8d3ca2bc93f2cae
Autor:
A. A. Vilnits, Yu. V. Lobzin, N. V. Skripchenko, L. N. Mazankova, O. I. Klimova, A. Yu. Rtishchev, I. M. Osmanov, K. V. Markova, N. H. Tkhakushinova, G. P. Martinova, A. U. Sabitov, R. K. Babik, I. Ya. Izvekova, V. V. Krasnov, E. V. Sidorenkova, O. V. Borisova, N. M. Bochkareva, O. V. Samodova, V. V. Sokolovskaya, A. A. Girina, A. Yu. Kurganskaya, E. M. Simovanyan, M. A. Kim, O. A. Rychkova, L. V. Khanipova, S. G. Grigorev
Publikováno v:
Журнал инфектологии, Vol 15, Iss 4, Pp 5-13 (2024)
The heavy burden of meningococcal infection is associated not only with life-threatening complications in the acute period and high mortality in invasive forms of the disease, but also with severe consequences in survivors, who are not recorded in ou
Externí odkaz:
https://doaj.org/article/70e2862ca52a4047a06cf88c3fb11f34
Autor:
A. U. Sabitov, L. P. Larionov, M. N. Dobrinskaya, O. V. Ledyankina, A. V. Osipenko, I. E. Valamina, E. V. Philippova, I. M. Fatikhov
Publikováno v:
Антибиотики и Химиотерапия, Vol 68, Iss 5-6, Pp 24-32 (2023)
The paper presents the results of extended preclinical studies demonstrating the safety using the direct-acting antiviral drug Riamilovir in immature white rats. Riamilovir did not show any toxic effects on the growth of animals, their fertility, beh
Externí odkaz:
https://doaj.org/article/227b867a61814c83a2f248ac31400cfe
Publikováno v:
Терапевтический архив, Vol 94, Iss 11, Pp 1278-1284 (2022)
Aim. Confirmation of the efficacy and safety of the drug riamilovir (Triazavirin), 100 mg capsules, in children aged 1217 years with the diagnosis of acute viral respiratory infection (ARVI). Materials and methods. The multicenter study included 2
Externí odkaz:
https://doaj.org/article/54b97e1ffa5f4607ada11071e38f2f67
Autor:
A. U. Sabitov, O. P. Kovtun, N. A. Batskalevich, N. I. Lvov, K. V. Zhdanov, E. V. Esaulenko, E. P. Tikhonova, Yu. S. Kalinina, P. V. Sorokin, S. V. Chepur, A. V. Stepanov
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 5-6, Pp 58-71 (2021)
The aim of the study was to carry out a meta-analysis of randomized clinical trials in order to combine the results of clinical trials on Triazavirin® (Riamilovir) efficacy in etiotropic therapy of influenza.Materials and methods. The analysis was
Externí odkaz:
https://doaj.org/article/100b48b39c0e41758fe5e4d404351e18
Autor:
A. U. Sabitov, O. P. Kovtun, N. A. Batskalevich, O. V. Maltsev, K. V. Zhdanov, E. V. Esaulenko, E. P. Tikhonova, Yu. S. Kalinina, P. V. Sorokin, S. V. Chepur, A. V. Stepanov
Publikováno v:
Антибиотики и Химиотерапия, Vol 66, Iss 5-6, Pp 48-57 (2021)
The aim of the study was to carry out meta-analysis of randomized controlled trials in order to combine the results of clinical trials on Triazavirin® (Riamilovir) efficacy in the etiotropic therapy of acute respiratory viral infection. Materials an
Externí odkaz:
https://doaj.org/article/6fdc02a953ae4c77805ebd38d81c8058
Publikováno v:
Терапевтический архив, Vol 93, Iss 4, Pp 435-439 (2021)
Aim. The assessment of the effectiveness, safety and tolerance of the drug Riamilovir for emergency drug prevention in the foci of a new coronavirus infection (COVID-19). Materials and methods. The trial included 113 persons aged 18 years and olde
Externí odkaz:
https://doaj.org/article/cf2f9ad54cd343fca78303fa3cfe11e6
Autor:
A. U. Sabitov, V. V. Belousov, A. S. Edin, E. V. Oleinichenko, E. P. Gladunova, E. P. Tikhonova, T. Yu. Kuzmina, Yu. S. Kalinina, P. V. Sorokin
Publikováno v:
Антибиотики и Химиотерапия, Vol 65, Iss 7-8, Pp 27-30 (2020)
The article evaluates the results of Riamilovir use in treatment of patients with a moderate form of the disease caused by a new strain of the SARS-CoV-2 virus. It was found that the average time required to complete resolution of symptoms during tre
Externí odkaz:
https://doaj.org/article/0138bad853fa459490bd1761644ad9da